BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9387619)

  • 1. [Organ transplantation infection and its prevention and treatment].
    Wang E; Liu Y
    Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):350-2. PubMed ID: 9387619
    [No Abstract]   [Full Text] [Related]  

  • 2. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
    Meylan PR; Pascual M
    Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status and impact of CMV prevention following pediatric organ transplantation.
    Allen UD
    Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425
    [No Abstract]   [Full Text] [Related]  

  • 4. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cytomegalovirus disease in transplant recipients.
    Snydman DR; Falagas ME
    Lancet; 1996 Jan; 347(8996):268-9. PubMed ID: 8551918
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of cytomegalovirus disease in transplant recipients.
    Winston DJ
    Lancet; 1995 Nov; 346(8987):1380-1. PubMed ID: 7475816
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of CMV infections in transplantation.
    Zaia JA
    Adv Exp Med Biol; 1996; 394():117-34. PubMed ID: 8815679
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune globulin versus antivirals versus combination for prevention of cytomegalovirus disease in transplant recipients.
    King SM
    Antiviral Res; 1999 Jan; 40(3):115-37. PubMed ID: 10027647
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytomegalovirus infections in transplant patients].
    Charpentier B
    Presse Med; 1991 Jun; 20(24):1107-8. PubMed ID: 1649473
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus: the taming of the beast?
    Goodrich J; Khardori N
    Lancet; 1997 Dec; 350(9093):1718-9. PubMed ID: 9413457
    [No Abstract]   [Full Text] [Related]  

  • 13. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
    Snydman DR
    Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
    [No Abstract]   [Full Text] [Related]  

  • 14. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients.
    Danziger-Isakov LA; Storch GA
    Pediatr Infect Dis J; 2002 May; 21(5):432-4. PubMed ID: 12150182
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of cytomegalovirus disease.
    Bailey TC
    Semin Respir Infect; 1993 Sep; 8(3):225-32. PubMed ID: 8016483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.
    Small LN; Lau J; Snydman DR
    Clin Infect Dis; 2006 Oct; 43(7):869-80. PubMed ID: 16941368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
    Stratta RJ; Pietrangeli C; Baillie GM
    Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management.
    Hanson KE; Swaminathan S
    Future Microbiol; 2015; 10(10):1545-8. PubMed ID: 26437628
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.